: Adjusted EBITDA Margin Unit (Million Baht) 3Q/16 2Q/17 3Q/17 % YoY % QoQ 9M/2016 9M/2017 % YoY FY 2016 Sales Revenue 3,901 4,826 5,180 33% 7% 13,080 14,253 9% 17,200 EBITDA 349 228 211 -40% -7% 1,192 751 -37
6,007.9 (3.6%) กาํไรสทุธ ิ 2,906.8 3,229.3 11.1% รายได้รวมจากการดาํเนินงาน/3(Normalized Total Revenue) 10,882.7* 13,058.7 20.0% กาํไรสุทธิจากการดาํเนินงาน/4 (Normalized Net Income) 2,422.8* 2,932.9 21.1% /1
source of long steady stream of revenue with low risk. The management of the company is expecting to start realize the income in the 3rd quarter of 2020, and will realize the income of all projects all
liabilities 0.87 52.39 Issued and paid-up capital 158.31 1.00 Unappropriated retained earnings (losses) (0.73) (0.73) Shareholders’ equity 157.10 0.27 Total revenues 0.00 0.00 Total selling and administration
drawn from the company’s retained earnings already subject to 30% corporate income tax. Payment date has been set for Tuesday, May 21, 2019. 2. The 5 directors due to retire upon term completion are as
potential projects. The Company is in the process of considering for the best benefit of the Company. However, the Company still has revenue from rental and service income. Including income from building
กําไรหรือขาดทุนจากการซื้อขายสัญญาซื้อขายลวงหนาที่เขาเงื่อนไขการรับรูรายการในสวน ของผูถือหุนตามที่กําหนดในหลักการบัญชี 26. กําไรสะสม (Retained earnings (deficits) ) 26.1 จัดสรรแลว (Appropriated
the sales income of 50.10MB from the divestment of Padaeng Industry (Laos) Co., Ltd., the company’s subsidiary. The H1 2017 selling and administrative expenses increased mainly from provisions for
Cost of sales and services (1,162.99) (892.84) (3,358.10) (3,111.44) Gross Profit 276.37 337.83 969.38 629.01 Gain/(Loss) on exchange rate (25.11) 20.66 (21.27) 30.44 Other Income 22.53 46.57 94.50
proportion of shareholding) Rationale and expected benefit : To cover intermediate care and wellness business, to expand business opportunities, to increase source of income for the company from new kind of